Alternative splicing in the vascular response to pathological shear stress
血管对病理剪切应力反应中的选择性剪接
基本信息
- 批准号:8312032
- 负责人:
- 金额:$ 4.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-03 至 2015-04-02
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAlternative SplicingAneurysmAntibodiesApolipoprotein EAreaArterial Fatty StreakAtherosclerosisBar CodesBiologicalBlood VesselsBlood flowCarotid ArteriesCellsCollagenComplexDepositionEndothelial CellsEndotheliumEventExonsExtracellular MatrixExtracellular Matrix ProteinsFibronectinsGene MutationGenesGenetic TranscriptionGrowthIn SituIn VitroInflammationInflammatoryInflammatory ResponseKnockout MiceLeukocytesLigationLinkLiquid substanceMeasuresMediator of activation proteinModelingMolecularMolecular AnalysisMorbidity - disease rateMusPathologyPatternPhenotypePlayProcessProtein IsoformsProteinsRNA SplicingRegulationReporterRoleSignal PathwaySignal TransductionSpliced GenesSpliceosomesTestingTranscriptUnited StatesVariantVascular Cell Adhesion Molecule-1Vascular DiseasesVascular EndotheliumVascular remodelingbiological adaptation to stressin vivoleukocyte activationmacrophagemonocytemortalityneointima formationpreventprotein expressionprotein functionreceptorresponserestenosisshear stresssmall hairpin RNA
项目摘要
DESCRIPTION (provided by applicant): Frictional forces exerted by blood flow on the vascular endothelium play an essential role in atherosclerosis, as well as aneurysm growth and pathological vascular remodeling. The endothelium expresses a similar profile of atheroprone, pro-inflammatory genes in response to low and oscillatory flow in all of these responses, suggesting fundamental molecular similarities. Although some of the immediate shear responsive signaling pathways have been identified, the downstream signaling which coordinates the vascular response remains unclear. Since vascular disease, the greatest cause of morbidity and mortality in the United States, is primarily caused by the formation of atherosclerotic plaques, understanding the mediators of the vascular response to altered blood flow is of critical importance. The extracellular matrix proteins underlying the endothelium dictat the inflammatory response to altered flow. A specific form of the secreted fibronectin protein, generated by alternative splicing of the constitutive transcript and normally absent in quiescent adult vasculature, is highly expressed in atherosclerotic lesions and other inflammatory vascular pathologies, such as aneurysm and neointima formation. Genetic mutations which prevent the formation of this isoform impair atherosclerosis in mice, but how this splicing is regulated and it biological consequences remain unclear. I hypothesize that alternative splicing of fibronectin in the endothelium is increased in response to atheroprone blood flow, and that the inclusion of alternative exons promotes atherosclerosis progression by promoting inflammatory cell recruitment and activation. To test this I will (1) Examine alternative splicing of fibronectin in response to atheroprone flow in vivo by molecular analysis of carotid arteries experimentally exposed to increased or decreased blood flow. I will then (2) Test the effect of deficient fibronectin splicing on monocyte recruitment/differentiation in the carotid arteries of mice unable
to produce specific (EIIIA and EIIIB) fibronectin isoforms. Finally, I will (3) Identify the regulaors of alternative splicing in the endothelial response to flow by using barcoded shRNA to screen endothelial cells expressing a fluorescent FN splicing reporter in vitro.
PUBLIC HEALTH RELEVANCE: Through alternative splicing, genes may encode diverse and even opposing protein functions. Thus, the regulation of alternative splicing by spliceosome complexes enables global regulation of protein function. We propose to test the regulation and function of alternative splicing of fibronectin, a critical component of extracellular matrix underlying the vascular endothelium in inflammatory vascular disease processes, such as atherosclerosis, aneurysm and restenosis.
描述(由申请人提供):血流对血管内皮施加的摩擦力在动脉粥样硬化以及动脉瘤生长和病理性血管重塑中起着重要作用。在所有这些反应中,内皮细胞在响应低流量和振荡流量时表达相似的易发生动脉粥样硬化的促炎症基因,这表明基本的分子相似性。尽管已经确定了一些直接剪切响应信号传导途径,但协调血管反应的下游信号传导仍不清楚。由于血管疾病是美国发病率和死亡率的最大原因,它主要是由动脉粥样硬化斑块的形成引起的,因此了解血管对血流改变的反应的介质至关重要。内皮细胞外基质蛋白决定了对血流改变的炎症反应。分泌型纤连蛋白的一种特定形式是由组成型转录物的选择性剪接产生的,通常在静止的成人脉管系统中不存在,在动脉粥样硬化病变和其他炎症性血管病变(例如动脉瘤和新内膜形成)中高度表达。阻止这种亚型形成的基因突变会损害小鼠的动脉粥样硬化,但这种剪接是如何调节的及其生物学后果仍不清楚。我推测,内皮细胞中纤连蛋白的选择性剪接会随着容易发生动脉粥样硬化的血流而增加,并且选择性外显子的包含会通过促进炎症细胞的募集和激活来促进动脉粥样硬化的进展。为了测试这一点,我将(1)通过对实验暴露于增加或减少的血流的颈动脉进行分子分析,检查纤连蛋白对体内动脉粥样硬化流的选择性剪接。然后,我将(2)测试纤连蛋白剪接缺陷对小鼠颈动脉中单核细胞募集/分化的影响
产生特定的(EIIIA 和 EIIIB)纤连蛋白亚型。最后,我将 (3) 通过使用条形码 shRNA 筛选体外表达荧光 FN 剪接报告基因的内皮细胞,鉴定内皮细胞对血流反应中选择性剪接的调节因子。
公共健康相关性:通过选择性剪接,基因可以编码多种甚至相反的蛋白质功能。因此,剪接体复合物对选择性剪接的调节能够实现蛋白质功能的全局调节。我们建议测试纤连蛋白选择性剪接的调节和功能,纤连蛋白是炎症性血管疾病过程中血管内皮细胞外基质的关键成分,例如动脉粥样硬化、动脉瘤和再狭窄。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Andries Murphy其他文献
Patrick Andries Murphy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Andries Murphy', 18)}}的其他基金
Regulation of Flt 1 Splicing by Fibronectin and Integrin Signaling During Aging
衰老过程中纤连蛋白和整合素信号传导对 Flt 1 剪接的调节
- 批准号:
10777172 - 财政年份:2023
- 资助金额:
$ 4.92万 - 项目类别:
RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity
RNA 结合蛋白在血管炎症和免疫调节中的作用
- 批准号:
10569122 - 财政年份:2021
- 资助金额:
$ 4.92万 - 项目类别:
RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity
RNA 结合蛋白在血管炎症和免疫调节中的作用
- 批准号:
10339436 - 财政年份:2021
- 资助金额:
$ 4.92万 - 项目类别:
Contributions of Endothelial RNA-binding Protein Dysregulation to Blood Brain Barrier Defects and Neurodegenerative Disease
内皮 RNA 结合蛋白失调对血脑屏障缺陷和神经退行性疾病的影响
- 批准号:
10037854 - 财政年份:2020
- 资助金额:
$ 4.92万 - 项目类别:
Investigation of alternative splicing in response to low and disturbed flow
针对低流量和扰动流量的选择性拼接研究
- 批准号:
9542878 - 财政年份:2015
- 资助金额:
$ 4.92万 - 项目类别:
Investigation of alternative splicing in response to low and disturbed flow
针对低流量和扰动流量的选择性拼接研究
- 批准号:
9335942 - 财政年份:2015
- 资助金额:
$ 4.92万 - 项目类别:
Alternative splicing in the vascular response to pathological shear stress
血管对病理剪切应力反应中的选择性剪接
- 批准号:
8458235 - 财政年份:2012
- 资助金额:
$ 4.92万 - 项目类别:
Alternative splicing in the vascular response to pathological shear stress
血管对病理剪切应力反应中的选择性剪接
- 批准号:
8649078 - 财政年份:2012
- 资助金额:
$ 4.92万 - 项目类别:
相似国自然基金
GSE1选择性剪接激活PI3K/Akt通路调控脂质代谢影响衰老进程的机制研究
- 批准号:82360286
- 批准年份:2023
- 资助金额:32.2 万元
- 项目类别:地区科学基金项目
PTBP1选择性剪接对Nogo/NgR信号的影响及其在PTSD靶向治疗中的作用与机制研究
- 批准号:82372508
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
UHRF1/DNMT1-MZF1轴调控PRSS3选择性剪接影响非小细胞肺癌功能异质性的表观机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
mRNA选择性剪接和2′-O-甲基化修饰对植物抗病基因多样性影响及对抗病功能调控的研究
- 批准号:32170218
- 批准年份:2021
- 资助金额:61 万元
- 项目类别:面上项目
遗传变异调控选择性剪接影响肺腺癌发生的分子流行病学研究
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 4.92万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 4.92万 - 项目类别:
Pre-mRNA Processing and Function of Alternatively Spliced Isoforms of TFPI
TFPI 选择性剪接亚型的前 mRNA 加工和功能
- 批准号:
10664506 - 财政年份:2023
- 资助金额:
$ 4.92万 - 项目类别:
Genetic and molecular basis of hematopoietic abnormalities in ZTTK syndrome
ZTTK 综合征造血异常的遗传和分子基础
- 批准号:
10644169 - 财政年份:2023
- 资助金额:
$ 4.92万 - 项目类别:
BIN1-interactome in Alzheimer's disease pathophysiology
BIN1-相互作用组在阿尔茨海默病病理生理学中的作用
- 批准号:
10677190 - 财政年份:2023
- 资助金额:
$ 4.92万 - 项目类别: